Skip to main content
. 2023 Feb 21;7(13):2972–2982. doi: 10.1182/bloodadvances.2022008364

Figure 3.

Figure 3.

The CIR, EFS, and OS of patients with RARG rearrangements (n = 34). CIR, cumulative incidence of relapse; EFS, event-free survival; OS, overall survival.